Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Hemodynamic Responses to Fluid and Vasopressor Resuscitation Strategies in Experimental Septic Shock: A Randomized Porcine Model Research Protocol [version 1; peer review: awaiting peer review]

Дата публикации: 25-07-2026 09:55:55

Introduction Septic shock is a condition resulting from an uncontrolled immune response to infection, leading to multi-organ failure. Fluid resuscitation is the primary initial therapy, but an aggressive approach risks fluid overload and increased extravascular lung water (EVLW). To date, direct comparative evidence between fluid-based resuscitation strategies, vasopressors, or a combination of both on hemodynamic changes is limited. This study aims to evaluate the differences in hemodynamic responses of these three strategies using the Sus scrofa domestica animal model. Methods This experimental study, conducted at the Veterinary Teaching Hospital of IPB University from November 2024 to January 2025, comprised 15 male Sus scrofa domestica, aged 16–20 weeks, weighing 40–60 kg, plus three controls. Randomization was performed using Random.org with allocation concealment, and procedures were standardized to minimize confounding. Septic shock was induced using lipopolysaccharide (E. coli O111:B4) until a MAP of

Основное содержимое страницы с новостью.

Introduction

Septic shock is characterized by an uncontrolled and excessive immune response to infection, which causes endothelial dysfunction, systemic vasodilation, increased vascular permeability, and impaired tissue perfusion leading to multi-organ failure.1,2 Septic shock remains a major issue as decades of research for a therapy that successfully address the host dysregulated, overshooting immune response is unavailable.3 Fluid resuscitation is a key component in the initial management of septic shock, however, an aggressive fluid resuscitation approach has received attention due to the potential for fluid overload, pulmonary edema, and increased extravascular lung water (EVLW).4,5

Understanding of the hemodynamic pathophysiology of septic shock has evolved regarding the role of systemic vasodilation and decreased systemic vascular resistance (SVR). This underlies the use of vasopressor as first-line therapy to maintain perfusion pressure by increasing vascular tone without significantly decreasing cardiac output.6 Meta-analysis showed that norepinephrine is effective in achieving target mean arterial pressure (MAP) and has a better safety profile than other vasopressors, although its impact on mortality is still variable.1

However, evidence regarding direct comparisons between fluid-based resuscitation strategies alone, vasopressors alone, or a combination of both on hemodynamic changes is still limited.7 We developed a Sus scrofa model as a sepsis animal model to study the hemodynamic differences between resuscitation using fluids alone, fluids with norepinephrine, and norepinephrine alone. We hypothesize that the combined fluid and norepinephrine strategy will achieve significantly different in hemodynamic response.

Protocol
Study design and setting

This experimental study was conducted from November 2024 to January 2025, at the Veterinary Teaching Hospital of the School of Veterinary Medicine and Biomedical Sciences, IPB University, Bogor, Indonesia. This research was approved by the animal ethics committee of the school of veterinary medicine and biomedicine, IPB University 266/KEH/SKE/2/2024. This research was conducted in accordance with the ARRIVE (Animal Research: Reporting of in vivo Experiments) guidelines.8,9

Study subjects and sample size

Animals were included if they met the following criteria: (1) male Sus scrofa domestica, (2) aged 16–20 weeks, (3) body weight 40–60 kg, and (4) developed septic shock during the experiment. Animals were excluded if they had been used in previous experiments or died from sepsis or septic shock prior to completion of data collection. The estimated sample size was determined using the resource equation10

E=N−T

10=(Nx3)−3

13=Nx3

N=13/3=4.34

Where:

E: Between 10–20.

N: Number of animals per treatment group multiplied by the number of treatment groups.

T: Number of treatments per group.

The sample size for this study was 4 Sus scrofa domestica calves per group. There were 3 groups in this study, so the total sample size required was 12 Sus scrofa domestica. The total sample size required was 15 Sus scrofa domestica in addition with 3 Sus scrofa domestica in control group.

Randomization

Randomization in this study was conducted using the Random.org website by a single research assistant who was not directly involved in the intervention process or outcome assessment. The results of the group allocation were not known to the rest of the research team until the time of treatment administration (allocation concealment). To reduce potential confounding factors, all study procedures were standardized, including a consistent order of treatment administration, uniform measurement times for each subject, and randomized subject assignment. Participants and outcome assessors were blinded to group allocation. The intervention was prepared and administered by designated personnel who were not involved in data collection or analysis. Data analysts were also blinded to group assignments during statistical analysis.

Materials and equipment

Equipment used included a CHI-SON Ebit60 Vet® ultrasound machine (CHISON Medical Technologies Co., Ltd., China), a Mindray® MEC 1000 patient monitor, and a transpulmonary thermodilution catheter system (PiCCO, PULSION Medical Systems SE, Munich, Germany), along with standard surgical instruments, ventilator support, and monitoring devices.

Pharmacological agents included ketamine 10%, xylazine 2%, fentanyl, propofol 0.1%, isoflurane 100%, norepinephrine, crystalloid solution (Ringer-Lactate), povidone-iodine 10%, alcohol 70%, marbofloxacin (Marbocyl® 10%), Hematodin®, Bio-din®, ivermectin®, and endotoxin lipopolysaccharide (E. coli 0111:B4). ELISA kits were used for measurement of IFABP, NT-proBNP, Syndecan-1, NGAL, and cystatin-C.

Animal preparation and acclimatization

The overall experimental setup and workflow are illustrated in Figure 1. Animals underwent a 10-day acclimatization period under controlled environmental conditions (temperature 18–26 °C; humidity >80%) with standard feeding twice daily and free access to water. Feeding was withheld for 6 hours prior to experimentation. During acclimatization, animals received prophylactic treatment consisting of marbofloxacin (1 mL/10 kg BW for 7 days), Hematodin® and Bio-din® (2 mL/50 kg BW on days 1, 3, and 7), ivermectin® (1 mL/50 kg BW subcutaneously), and fenbendazole (4 mL/50 kg BW orally).11,12

5292b0a5-a071-4ff9-b5cb-9695211f7140_figure1.gif

Figure 1. Experimental porcine model of septic shock with invasive hemodynamic monitoring.

Animals were anesthetized, intubated, and mechanically ventilated, with placement of arterial and central venous catheters, as well as a PiCCO catheter for transpulmonary thermodilution monitoring. Septic shock was induced using lipopolysaccharide (E. coli O111:B4), followed by randomization into fluid-first, vasopressor-first, and combined resuscitation groups. Hemodynamic parameters and laboratory measurements were recorded according to the study protocol.

Instrumentation and septic shock induction

Anesthesia was induced using intramuscular ketamine (10 mg/kg BW) and xylazine (2 mg/kg BW), followed by endotracheal intubation after propofol administration (4–6 mg/kg BW). Animals were mechanically ventilated (tidal volume 8 mL/kg, PEEP 4 cmH₂O, FiO₂ 0.4), and anesthesia was maintained with isoflurane (2%). A 22G intravenous catheter was inserted into the auricular vein for fluid administration (0.9% NaCl at 3 mL/kg/hour). Urinary catheterization was performed. Hemodynamic monitoring included electrocardiography (ECG), echocardiography (ECHO), and ultrasonography (USG). After stabilization, a PiCCO catheter was inserted via the jugular vein. Baseline blood samples and hemodynamic measurements were obtained within 10–15 minutes after stabilization. Septic shock was induced using intravenous infusion of lipopolysaccharide (E. coli 0111:B4; 20 mg diluted in 20 mL sterile water). Septic shock was defined as a decrease in MAP to <65 mmHg.3,13

Resuscitation protocol and randomization

Following septic shock induction, animals were randomized into three resuscitation strategies. In the fluid-first group, resuscitation was initiated with a 30 mL/kg crystalloid bolus administered over 30 minutes and repeated if the target mean arterial pressure (MAP ≥65 mmHg) was not achieved; persistent hypotension was managed with norepinephrine titrated from 0.1 to 0.3 mcg/kg/min. In the vasopressor-first group, norepinephrine was initiated at 0.1 mcg/kg/min and combined with a 3 mL/kg crystalloid bolus, with dose escalation to 0.2–0.3 mcg/kg/min as needed to achieve the target MAP. In the combined group, animals received simultaneous administration of a 30 mL/kg crystalloid bolus and norepinephrine at 0.1 mcg/kg/min, followed by stepwise escalation of norepinephrine (0.2–0.3 mcg/kg/min) if the target MAP was not reached. Control groups followed identical protocols without induction of septic shock. At the conclusion of the experiment, animals were euthanized under anesthesia using magnesium sulfate (MgSO₄) and subsequently cremated. This method was selected because it provides rapid cardiac arrest in anesthetized animals.

Outcome measurements

The study outcomes were assessed based on: Achievement of the target MAP ≥65 mmHg. Primary outcome: Hemodynamics: MAP, CI, SVRI, SVI, GEDVI, ELWI. Secondary outcome: IFABP, lactate, Hb, Oxygen transport: DO₂ and CaO₂. Furthermore, treatment failure was defined as failure to achieve the target MAP after three protocol escalations. Samples that failed to reach the MAP target were still included in the study. The amount of fluid is determined based on: Bolus administered according to the group protocol (30 mL/kg or 3 mL/kg). Repeat bolus administration if the target MAP of ≥65 mmHg has not been achieved. There is no other specific method for measuring total fluid volume (e.g., cumulative fluid balance).

Animal welfare and monitoring

Animal welfare was prioritized in accordance with institutional ethical standards and the ARRIVE 2.0 guidelines. Clinical signs of pain, distress, or physiological deterioration were documented and assessed by the research team and attending veterinarian. To minimize pain and distress, all invasive procedures were performed under general anesthesia induced with ketamine and xylazine and maintained with propofol and isoflurane as described in the protocol.

Statistical analysis

Data were presented as mean ± standard deviation for normally distributed variables and median (minimum–maximum) for non-normally distributed variables. Normality testing was performed prior to analysis. Comparisons between two groups were conducted using Independent t-test or Mann–Whitney U test, while paired comparisons used Paired t-test or Wilcoxon test. Comparisons among three or more groups were analyzed using One-way ANOVA or Kruskal–Wallis test. Correlation analyses were performed using Pearson or Spearman tests as appropriate. Statistical significance was defined as p < 0.05. Statistical analyses were performed using IBM SPSS Statistics version 32 (IBM Corp., Armonk, NY, USA).

Discussion

The current protocol was created to assess three resuscitation techniques: fluid-first, vasopressor-first, and combined fluid-vasopressor therapy in controlled porcine model of septic shock. Porcine are one of the most relevant large-animal models for sepsis research because their cardiovascular system, size, and blood flow responses closely resemble those of humans.14 Recent reviews highlight that porcine models of septic shock offer better insight compared to small-animal models. They also allow monitoring methods that closely mimic intensive care management in human patients.15 A key strength of this study is the use of invasive transpulmonary thermodilution monitoring (PiCCO). This allows detailed study of preload, cardiac performance, vascular resistance and fluid accumulation in the lungs.16 The study is also expected to contribute to the ongoing debate about initiation of vasopressor treatment. There is increasing evidence that earlier initiation of vasopressors can contribute to the reduction of the amount of intravenous fluids needed for hemodynamic stability. This may contribute to prevention of fluid overload and tissue swelling.17,18 However, adequate fluid resuscitation remains critical to optimize heart preload and to ensure proper reaction to vasopressor therapy.19,20 By comparing fluid-first, vasopressor-first and combined approaches under controlled conditions, this study may provide insight into the interaction between vascular tone, blood volume and oxygen delivery during septic shock.

Several limitations need to be noted. Even with careful standardization, biological differences among the animals can affect their responses to endotoxin exposure and resuscitation. Variations in initial blood volume might also impact the ability to reach target MAP and other blood flow outcomes.21 Endotoxin-induced septic shock mimics many hemodynamic features of human sepsis. However, it may not completely represent the complexity of real clinical infections where pathogen-host interactions occur.22

Conclusion

This study is expected to provide an essential experimental platform to evaluate hemodynamic responses in septic shock using a controlled Sus scrofa domestica model. By directly comparing fluid-first, vasopressor-first, and combined resuscitation strategies, this study will generate mechanistic insights into the interplay between intravascular volume, vascular tone, and tissue perfusion, particularly in achieving target mean arterial pressure (MAP).

The challenge in this study is the potential for uncontrolled differences in intravascular volume between subjects, which could influence the hemodynamic response to resuscitation, potentially confounding the achievement of MAP targets and changes in other parameters such as ELWI and DO₂. Furthermore, the relatively small sample size makes it likely that some clinically significant differences may not reach statistical significance.

Dissemination of results

The results of this study will be disseminated through publication in a peer-reviewed open-access journal and presentation at relevant scientific conferences. The findings are expected to contribute to the understanding of hemodynamic resuscitation strategies in septic shock and may inform future experimental and clinical research. Any data generated from this study will be made available in an appropriate public repository in accordance with journal policies.

Data availability statement

No data are associated with this article. Open Science Framework.

Acknowledgement

The authors would like to thank the staff of the Veterinary Teaching Hospital, School of Veterinary Medicine and Biomedical Sciences, IPB University, Bogor, Indonesia, for their technical assistance in research process.

References
  • 1.  Ruslan MA, Baharuddin KA, Noor NM, et al.: Norepinephrine in Septic Shock: A Systematic Review and Meta-analysis. West. J. Emerg. Med. 2021; 22: 196–203. PubMed Abstract | Publisher Full Text | Free Full Text
  • 2.  Kotani Y, Ryan N, Udy AA, et al.: Haemodynamic management of septic shock. Burns Trauma. 2025; 13: tkae081. PubMed Abstract | Publisher Full Text | Free Full Text
  • 3.  Zurek-Leffers FM, Lehmann F, Brabenec L, et al.: A model of porcine polymicrobial septic shock. Intensive Care Med. Exp. 2023; 11: 31. PubMed Abstract | Publisher Full Text | Free Full Text
  • 4.  Brandt S, Regueira T, Bracht H, et al.: Effect of fluid resuscitation on mortality and organ function in experimental sepsis models. Crit. Care. 2009; 13: R186. PubMed Abstract | Publisher Full Text | Free Full Text
  • 5.  Hu W, Lin CW, Liu BW, et al.: Extravascular lung water and pulmonary arterial wedge pressure for fluid management in patients with acute respiratory distress syndrome. Multidiscip. Respir. Med. 2014; 9: 3. PubMed Abstract | Publisher Full Text | Free Full Text
  • 6.  Xu QY, Jin YH, Fu L, et al.: Application of norepinephrine in the treatment of septic shock: a meta-analysis. Ir. J. Med. Sci. 2025; 194: 361–369. PubMed Abstract | Publisher Full Text | Free Full Text
  • 7.  Graham JD, Lanspa MJ, Peltan ID: Resuscitation Targets, Fluids, and Vasoactives in Septic Shock. Clin. Chest Med. 2026; 47: 33–43. PubMed Abstract | Publisher Full Text | Free Full Text
  • 8.  The ARRIVE guidelines 2.0|ARRIVE Guidelines: [cited 2026 Apr 28]. Reference Source
  • 9.  du Sert NP , Ahluwalia A, Alam S, et al.: Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol. 2020; 18: e3000411. PubMed Abstract | Publisher Full Text | Free Full Text
  • 10.  Charan J, Kantharia ND: How to calculate sample size in animal studies?. J. Pharmacol. Pharmacother. 2013; 4: 303–306. PubMed Abstract | Publisher Full Text | Free Full Text
  • 11.  Pudjiadi AH: Pengaruh Resusitasi Cairan terhadap Hemodinamik Sus Scrofa Sebagai Model Renjatan: Kajian pada Atrial Natriuretic Peptide, Glycocalyx Endotel, dan Pasokan Oksigen [Disertasi]. Jakarta: Universitas Indonesia; 2018.
  • 12.  Pudjiadi AH, Firmansyah A, Gunanti M, et al.: Resuscitation of hemorrhagic shock using normal saline does not damage the glycocalyx in the immediate resuscitation phase. Turk J. Emerg. Med. 2022; 22: 23–28. PubMed Abstract | Publisher Full Text | Free Full Text
  • 13.  Martikainen TJ, Uusaro A, Tenhunen JJ, et al.: Dobutamine compensates deleterious hemodynamic and metabolic effects of vasopressin in the splanchnic region in endotoxin shock. Acta Anaesthesiol. Scand. 2004; 48: 935–943. PubMed Abstract | Publisher Full Text
  • 14.  Kubiak BD, Albert SP, Gatto LA, et al.: A Clinically Applicable Porcine Model of Septic and Ischemia/Reperfusion-Induced Shock and Multiple Organ Injury. J. Surg. Res. 2011; 166: e59–e69. PubMed Abstract | Publisher Full Text | Free Full Text
  • 15.  Vintrych P, Al-Obeidallah M, Horák J, et al.: Modeling sepsis, with a special focus on large animal models of porcine peritonitis and bacteremia. Front. Physiol. 2023; 13: 1094199. PubMed Abstract | Publisher Full Text | Free Full Text
  • 16.  Ritter S, Rudiger A, Maggiorini M: Transpulmonary thermodilution-derived cardiac function index identifies cardiac dysfunction in acute heart failure and septic patients: an observational study. Crit. Care. 2009; 13: R133. PubMed Abstract | Publisher Full Text | Free Full Text
  • 17.  Macdonald S, Peake SL, Corfield AR, et al.: Fluids or vasopressors for the initial resuscitation of septic shock. Front. Med. 2022; 9. PubMed Abstract | Publisher Full Text | Free Full Text
  • 18.  Macdonald SPJ, Keijzers G, Taylor DM, et al.: Restricted fluid resuscitation in suspected sepsis associated hypotension (REFRESH): a pilot randomised controlled trial. Intensive Care Med. 2018; 44: 2070–2078. PubMed Abstract | Publisher Full Text
  • 19.  Macdonald S: Fluid Resuscitation in Patients Presenting with Sepsis: Current Insights. Open Access Emerg Med. 2022; 14: 633–638. PubMed Abstract | Publisher Full Text | Free Full Text
  • 20.  Nelakuditi M, Bawankule S: Evaluating the impact of early vs. late vasopressor use on outcomes in sepsis patients: A systematic review. Multidisciplinary Reviews. 2025; 8: 2025249–2025249. Publisher Full Text
  • 21.  Kattan E, Ospina-Tascón GA, Teboul JL, et al.: Systematic assessment of fluid responsiveness during early septic shock resuscitation: secondary analysis of the ANDROMEDA-SHOCK trial. Crit. Care. 2020; 24: 23. PubMed Abstract | Publisher Full Text | Free Full Text
  • 22.  Anel R, Kumar A: Human endotoxemia and human sepsis: limits to the model. Crit. Care. 2005; 9: 151–152. PubMed Abstract | Publisher Full Text | Free Full Text
  • 23.  Lubis AD: ARRIVE 2.0 Author Checklist for “Hemodynamic Responses to Fluid and Vasopressor Resuscitation Strategies in Experimental Septic Shock: A Randomized Porcine Model Research Protocol”. Open Science Framework (OSF). 2025. Publisher Full Text

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Protocol for a Multicentre Mixed-Methods Observational Cohort Study Investigating Early Sepsis Management in Ghanaian Emergency Departments and Intensive Care Units [version 1; peer review: awaiting peer review]09.7823-07-2026
2Operational Feasibility of A Priori Covariate-Based Meropenem Exposure Prediction Using a Southeast Asian Population Pharmacokinetic Model in Indonesian Critically Ill Patients with Sepsis [version 1; peer review: awaiting peer review]010.1227-07-2026
3Accuracy of Systemic Inflammatory Indices in Identifying Neonatal Sepsis in Preterms in a Tertiary Care Hospital in Mangalore [version 4; peer review: 2 approved, 2 approved with reservations, 1 not approved]07.4429-07-2026
4Интенсив «Печень в критическом состоянии: алгоритмы стабилизации в ОРИТ», лектор Яна Старокожева, 18.070721-05-2026
5Risk Factor on Bleeding Event after Intravenous Alteplase Therapy in Acute Ischaemic Stroke [version 1; peer review: 1 approved with reservations]07.4830-07-2026
6A Comprehensive Analysis of Sodium, Potassium, Calcium, Magnesium,IL-1β, IL-6, and TNF-α, and Periventricular Hypodensity as Contributing Factors to Pre-Shunt Seizures in Hydrocephalic Children [version 1; peer review: 1 not approved]09.215-07-2026
7Vascular Access Type and Survival Outcomes in Hemodialysis Patients [version 1; peer review: awaiting peer review]06.611-07-2026
8Курс «Респираторная недостаточность и ИВЛ у собак и кошек», лектор Маргарита Тлехас, 10.08-18.080703-07-2026
9Курс «Анемия в ОРИТ: от гемопоэза до гемотрансфузии», лектор Елена Изотова, 17.08-21.090809-06-2026
10Documented Health System and Clinician-related Challenges among Neonatal Deaths at a Rural District Hospital, Eastern Cape, South Africa: A Retrospective Descriptive Study (2019–2025) [version 1; peer review: awaiting peer review]07.831-07-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 7.52. Источник: f1000research.com.